Ticker
  • Companies
  • RNS
  • AI Chat
  • Research
  • Indices
  • Ticker TV
  • Events
  • Commodities
  • Currencies
Ticker
⌘K
Developer PortalNewsServices
/Equities/AIMX/TSTL
OverviewShare PriceRNSTradesShort InterestDirectorsHoldings
Tristel PLC logo
Tristel PLC
/Equities/AIMX/TSTL
OverviewShare PriceRNSTradesShort InterestDirectorsHoldings
Tristel PLC logo

Tristel PLC

Loading price data...
--
--

Price Chart

Open
395.00
High
410.00
Low
390.00
Close
404.05
Change
+8.00 (2.04%)
Volume
86,364

Recent RNS announcements

20 Apr 202614:28:29Holding(s) in Company
20 Apr 202608:20:55Holding(s) in Company
23 Mar 202607:00:12Director/PDMR Shareholding
18 Mar 202607:00:12Conference attendance at ShareSoc Leeds
17 Mar 202617:13:53Holding(s) in Company

Annual Reports

30 Oct 2025Annual Report and Accounts (to 2025-06-30)
16 Dec 2024Annual Report and Accounts (to 2024-06-30)
22 Dec 2023Annual Report and Accounts (to 2023-06-30)

Directors (9)

MG
Matthew Giovanni SassoneChief Executive Officer
1 yrs 8 mos
AK
Anna Katarzyna WasylChief Financial Officer
8 mos
JS
Julija ShabanovaExecutive Director
–
SG
Steve GarrodExecutive Director
–
TP
Tristel Plc
–

In the Press

2 Mar 2026Find out how Tristel could ‘clean up’ in the USSharesify
22 Jan 2026Tristel confirms FY outlookSharesify
22 Jan 2026Tristel reveals strong start to yearSharesify

Company details

Tristel plc (AIM: TSTL) produces products for controlling infections, contamination, and maintaining hygiene.

Industry
Health Care
Sector
Health Care
LEI
2138009DZ4LH9CZGF662
Region
Europe
Admission date
1 Jun 2005
Website
tristel.com

Shares details

Shares in issue
47,921,543
Total Voting Rights
47,921,543
Last updated: 1 May 2026

Instrument details

ISIN
GB00B07RVT99
Exchange
AIMX
Market
Aim
Market Segment
ASQ1
Market Sector
AMQ1
Loading price data...
--
--

Price Chart

Open
395.00
High
410.00
Low
390.00
Close
404.05
Change
+8.00 (2.04%)
Volume
86,364

Recent RNS announcements

20 Apr 202614:28:29Holding(s) in Company
20 Apr 202608:20:55Holding(s) in Company
23 Mar 202607:00:12Director/PDMR Shareholding
18 Mar 202607:00:12Conference attendance at ShareSoc Leeds
17 Mar 202617:13:53Holding(s) in Company

Annual Reports

30 Oct 2025Annual Report and Accounts (to 2025-06-30)
16 Dec 2024Annual Report and Accounts (to 2024-06-30)
22 Dec 2023Annual Report and Accounts (to 2023-06-30)

Directors (9)

MG
Matthew Giovanni SassoneChief Executive Officer
1 yrs 8 mos
AK
Anna Katarzyna WasylChief Financial Officer
8 mos
JS
Julija ShabanovaExecutive Director
–
SG
Steve GarrodExecutive Director
–
TP
Tristel Plc
–

In the Press

2 Mar 2026Find out how Tristel could ‘clean up’ in the USSharesify
22 Jan 2026Tristel confirms FY outlookSharesify
22 Jan 2026Tristel reveals strong start to yearSharesify

Company details

Tristel plc (AIM: TSTL) produces products for controlling infections, contamination, and maintaining hygiene.

Industry
Health Care
Sector
Health Care
LEI
2138009DZ4LH9CZGF662
Region
Europe
Admission date
1 Jun 2005
Website
tristel.com

Shares details

Shares in issue
47,921,543
Total Voting Rights
47,921,543
Last updated: 1 May 2026

Instrument details

ISIN
GB00B07RVT99
Exchange
AIMX
Market
Aim
Market Segment
ASQ1
Market Sector
AMQ1
Share Price404.05p
Day Change+8.00p(+2.04%)
Market Cap£193.6m
1 May 15:27
Market closed
Share Price404.05p
Day Change+8.00p(+2.04%)
Market Cap£193.6m
1 May 15:27
Market closed